Skip to main content

Table 3 Incremental costs, QALYs DW gained and ICERs per individual 12-year-old over their whole lives (expected value analysis)

From: Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program

  Baseline Each intervention compared to no HPV vaccination Incremental comparisons
Intervention 1G:Replicating the girls-onlyNZ program in 2011 Intervention 2G:Intensive girls-onlyprogram, school-based Intervention 1G + B:Adding boysto the girlsNZ program in 2011 Intervention 2G + B:Adding boysto the intensive girlsprogram, school-based [A] Intervention 2G c.f. Intervention 1G [B] Intervention 1G + B c.f. Intervention1G [D] Intervention 2G + B c.f. Intervention 2G
Net cost (NZ$)
Total population $43,807 $81 $129 $235 $372 $47 $154 $244
QALYs DW gained (all individuals regardless of vaccination status)
Total population 26.2830 0.0045 0.0059 0.0059 0.0069 0.0014 0.0014 0.0010
Males 26.3533 0.0025 0.0032 0.0033 0.0038 0.0007 0.0009 0.0006
Females 26.2092 0.0066 0.0087 0.0085 0.0102 0.0021 0.0019 0.0015
ICER*
Total population   $18,100 $21,900 m $53,700 $34,000 $111,000 $234,000
  1. *All ICERs rounded to nearest $100 or nearest $1,000 if > $100,000.